Repurposing multiple sclerosis drug dimethyl fumarate, a promising fast track candidate for systemic cutaneous T cell lymphoma treatment

被引：0
|
作者：
Herold, Martin [1 ]
Klotz, Luisa [1 ]
机构：
[1] Univ Munster, Dept Neurol, D-48149 Munster, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
FACTOR-KAPPA-B; MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; NUCLEAR-FACTOR; ACTIVATION; APOPTOSIS; PATHWAY; ACID; NRF2; SENSITIVITY;
D O I：
10.21037/tcr.2016.12.54
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1453 / S1456
页数：4
相关论文
共 50 条
  • [1] Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
    Liebmann, Marie
    Janoschka, Claudia
    Herrmann, Alexander
    Korn, Lisanne
    Schulte-Mecklenbeck, Andreas
    Schwab, Nicholas
    Kovac, Stjepana
    Gross, Catharina C.
    Konig, Simone
    Meuth, Sven
    Wiendl, Heinz
    Klotz, Luisa
    NEUROLOGY, 2020, 94 (15)
  • [2] Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
    Liebmann, M.
    Janoschka, C.
    Heimann, A.
    Schulte-Mecklenbeck, A.
    Schwab, N.
    Gross, C. C.
    Meuth, S. G.
    Wiendl, H.
    Klotz, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 475 - 476
  • [3] Dimethyl Fumarate Treatment alters T Cell Metabolism in Multiple Sclerosis
    Liebmann, Marie
    Janoschka, Claudia
    Herrmann, Alexander
    Schulte-Mecklenbeck, Andreas
    Schwab, Nicolas
    Gross, Catharina C.
    Meuth, Sven G.
    Wiendl, Heinz
    Klotz, Luisa
    NEUROLOGY, 2018, 90
  • [4] Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
    Liebmann, M.
    Janoschka, C.
    Herrmann, A.
    Schulte-Mecklenbeck, A.
    Schwab, N.
    Gross, C. C.
    Koenig, S.
    Meuth, S. G.
    Wiendl, H.
    Klotz, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 748 - 749
  • [5] Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
    Gross, Catharina C.
    Schulte-Mecklenbeck, Andreas
    Klinsing, Svenja
    Posevitz-Fejfar, Anita
    Wiendl, Heinz
    Klotz, Luisa
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [6] Dimethyl fumarate treatment alters NK cell function in multiple sclerosis
    Smith, Matthew D.
    Calabresi, Peter A.
    Bhargava, Pavan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (02) : 380 - 383
  • [7] Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
    Nicolay, Jan P.
    Melchers, Susanne
    Albrecht, Jana D.
    Assaf, Chalid
    Dippel, Edgar
    Stadler, Rudolf
    Wehkamp, Ulrike
    Wobser, Marion
    Zhao, Jing
    Burghaus, Ina
    Schneider, Sven
    Guelow, Karsten
    Goerdt, Sergij
    Schuerch, Christian M.
    Utikal, Jochen S.
    Krammer, Peter H.
    BLOOD, 2023, 142 (09) : 794 - 805
  • [8] Treatment response to dimethyl fumarate is characterized by CD8+T cell reduction in multiple sclerosis
    Luessi, F.
    Fleischer, V.
    Friedrich, M.
    Rezk, A.
    Buehler, U.
    Witsch, E.
    Uphaus, T.
    Bittner, S.
    Groppa, S.
    Bar-Or, A.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 673 - 674
  • [9] Optimal Drug Treatment for Cutaneous T Cell Lymphoma
    Brigitte Dréno
    Olivier Jumbou
    BioDrugs, 1997, 7 : 254 - 261
  • [10] Optimal drug treatment for cutaneous T cell lymphoma
    Dreno, B
    Jumbou, O
    BIODRUGS, 1997, 7 (04) : 254 - 261
12345